{"id":"W2054340543","doi":"10.1016/s1470-2045(13)70473-x","title":"Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Pemetrexed; Docetaxel; Cetuximab; Medicine; Oncology; Internal medicine; Open label; Lung cancer; Chemotherapy; Clinical trial; Cancer; Colorectal cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003937198,0.0003579737,0.001320023,0.0001191078,0.0001233491,0.00008472712,0.0003466245,0.0001443556,0.003165899],"category_scores_gemma":[0.00007888036,0.0001452979,0.00005502197,0.0004499257,0.0001603344,0.0001324987,0.00006412282,0.0003648055,0.00002288339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005255929,"about_ca_system_score_gemma":0.00316865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007219877,"about_ca_topic_score_gemma":0.002830722,"domain_scores_codex":[0.9978858,0.0003215053,0.0004919766,0.0004788099,0.0002325846,0.0005893374],"domain_scores_gemma":[0.9982651,0.0004861412,0.000382902,0.000515249,0.0001926974,0.0001579121],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9417759,0.006504459,0.003113013,0.0001572697,0.0005726591,0.0004377797,0.002908014,0.00001015586,0.0002798905,0.000002185723,0.00484413,0.03939452],"study_design_scores_gemma":[0.9664498,0.01893909,0.0007865006,0.000466052,0.0008165133,0.00004216457,0.0003524552,0.00268631,0.0005147098,0.000007788388,0.008659624,0.0002790127],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9721439,0.001418151,0.00009620254,0.006255874,0.0003851796,0.01746781,0.00007489869,0.00005886622,0.002099056],"genre_scores_gemma":[0.9541913,0.0004388857,0.005122814,0.004153549,0.0007752236,0.03071021,0.00007308811,0.00007455626,0.00446043],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0391155,"threshold_uncertainty_score":0.9977453,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07556084289108853,"score_gpt":0.4426476036905805,"score_spread":0.367086760799492,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}